Latest News about REGN
Recent news which mentions REGN
FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why
January 24, 2022
From Benzinga
Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?
January 24, 2022
From Benzinga
Second Dupixent Phase 3 Trial Confirms Significant Improvements In Inflammatory Skin Disease
January 19, 2022
From Benzinga
The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data
January 19, 2022
From Benzinga
Regeneron Announces FDA Accepts For Review Libtayo In Combination With Chemotherapy For First-Line Treatment Of Advanced NSCLC
January 19, 2022
Tickers
REGN
From Benzinga
2 Top Biotech Stocks to Buy and Hold for 10 Years
January 17, 2022
From Motley Fool
3 Top Biotech Stocks to Buy Right Now
January 15, 2022
From Motley Fool
From Benzinga
From Benzinga
From Motley Fool
Why JPMorgan Is Among Rob Sechan's Top Picks For 2022
January 10, 2022
From Benzinga
Why This Pfizer, Regeneron Analyst Has Contrasting Recommendations For The COVID Stock Plays
January 05, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2022
January 05, 2022
From Benzinga
3 Healthcare Stocks That Could Rocket Higher in 2022
January 04, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022
January 03, 2022
From Benzinga
Better Buy: CRISPR vs. Intellia
January 03, 2022
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
December 31, 2021
From Benzinga
Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
December 29, 2021
From Benzinga
AstraZeneca's COVID-19 Antibody Effective Against Omicron Variant
December 16, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
December 15, 2021
From Benzinga
2 No-Brainer Healthcare Stocks to Buy Right Now
December 13, 2021
From Motley Fool
Novartis Reveals Two Year Results From Beovu Trial In Diabetic Macular Edema Patients
December 09, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
From Benzinga
Vir, GSK’s COVID-19 antibody treatment works against omicron in a lab study, and WHO no longer recommends convalescent plasma
December 07, 2021
From MarketWatch
2 Big Stock Bets That Are Insiders Are Buying Now
December 06, 2021
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
December 06, 2021
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
Regeneron: Surfing on Covid, With More Under the Surface
December 02, 2021
From InvestorPlace
Why Are Stocks Down Today? 4 Things to Know.
November 30, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.